Trademark: 97842069
Word
EPISCORE
Status
Pending
Status Code
686
Status Date
Tuesday, September 24, 2024
Serial Number
97842069
Mark Type
4
Filing Date
Thursday, March 16, 2023
Published for Opposition
Tuesday, September 24, 2024

Trademark Owner History
Nucleix Limited - Owner At Publication

Classifications
5 Diagnostic test kits for medical and clinical use comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic assay kits comprised of medical diagnostic reagents for use in identifying and measuring changes associated with cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, precancerous conditions, chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease in the field of cancer detection, detection of or chronic obstructive pulmonary disease (COPD), autoimmune disease and neurological disease; diagnostic reagents for medical purposes
44 Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease and prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease; providing cancer screening services; providing medical screening services for chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease; providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD) and autoimmune disease and neurological disease
10 Medical apparatus for medical diagnostic testing in the fields of cancer and chronic obstructive pulmonary disease (COPD)
EPIS CORE

Trademark Events
Mar 20, 2023
New Application Entered
Apr 8, 2023
New Application Office Supplied Data Entered
Dec 13, 2023
Assigned To Examiner
Jan 4, 2024
Non-Final Action Written
Jan 4, 2024
Non-Final Action E-Mailed
Jan 4, 2024
Notification Of Non-Final Action E-Mailed
Aug 17, 2024
Assigned To Lie
Aug 18, 2024
Correspondence Received In Law Office
Aug 19, 2024
Approved For Pub - Principal Register
Sep 4, 2024
Notification Of Notice Of Publication E-Mailed
Sep 24, 2024
Published For Opposition
Sep 24, 2024
Official Gazette Publication Confirmation E-Mailed
Aug 18, 2024
Teas/Email Correspondence Entered
Mar 4, 2024
Teas Response To Office Action Received

Trademark Alertz updated from USPTO on 2030-01-24